Brigatinib: New-generation ALK inhibitor for nonsmall cell lung cancer

Umbela, S; Ghacha, S; Matuknauth, R; Gause, S; Joshee, S; Deshmukh, RR

Deshmukh, RR (reprint author), LECOM, Sch Pharm, Bradenton, FL 34211 USA.

CURRENT PROBLEMS IN CANCER, 2019; 43 (6):

Abstract

Lung cancer, specifically nonsmall cell lung cancer (NSCLC) is the leading cause of death around the world. First-line therapies for metastatic NSCLC ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索